Loading resource…

The ARISE FLUIDS Investigators, the ANZICS Clinical Trials Group, and the ACEM Clinical Trials Network
The research randomly assigned adult patients with septic shock to receive either early vasopressor therapy with restricted fluid volumes or higher volumes of fluids with delayed vasopressor therapy. The primary outcome measured was the number of days alive and out of the hospital at day 90. The study aimed to determine the effectiveness and safety of these two resuscitation strategies in a clinical setting.
No account needed